The drug 2-deoxy-D-glucose has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), along with Dr Reddy's Laboratories (DRL), Hyderabad.
The first batch of DRDO-developed anti-Covid drug 2-DG (2-deoxy-D-glucose) was launched on Monday to treat patients suffering from the deadly disease. The medicine comes in powder form and can be taken with water.
New Delhi: Sun Pharmaceutical Industries Ltd on Tuesday announced the launch of Favipiravir, under brand name FluGuard, at Rs 35 per tablet for the treatment of mild to moderate cases of Covid-19 in India. Favipiravir is an oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate Covid-19 disease. […]